225 related articles for article (PubMed ID: 12599079)
41. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
42. In vitro activities of different inhibitors of bacterial transcription against Staphylococcus epidermidis biofilm.
Villain-Guillot P; Gualtieri M; Bastide L; Leonetti JP
Antimicrob Agents Chemother; 2007 Sep; 51(9):3117-21. PubMed ID: 17606690
[TBL] [Abstract][Full Text] [Related]
43. Prevention of Staphylococcus aureus biofilm on dialysis catheters and adherence to human cells.
Balaban N; Gov Y; Bitler A; Boelaert JR
Kidney Int; 2003 Jan; 63(1):340-5. PubMed ID: 12472801
[TBL] [Abstract][Full Text] [Related]
44. Telavancin: in vitro activity against staphylococci in a biofilm model.
Gander S; Kinnaird A; Finch R
J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
[TBL] [Abstract][Full Text] [Related]
45. In vitro S. epidermidis and S. aureus adherence to composite and lightweight polypropylene grafts.
Aydinuraz K; Ağalar C; Ağalar F; Ceken S; Duruyürek N; Vural T
J Surg Res; 2009 Nov; 157(1):e79-86. PubMed ID: 19592038
[TBL] [Abstract][Full Text] [Related]
46. The role of extracellular polymers on Staphylococcus epidermidis biofilm biomass and metabolic activity.
Sousa C; Teixeira P; Oliveira R
J Basic Microbiol; 2009 Aug; 49(4):363-70. PubMed ID: 19219902
[TBL] [Abstract][Full Text] [Related]
47. Nosocomial infections by Staphylococcus epidermidis: how a commensal bacterium turns into a pathogen.
Ziebuhr W; Hennig S; Eckart M; Kränzler H; Batzilla C; Kozitskaya S
Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S14-20. PubMed ID: 16829054
[TBL] [Abstract][Full Text] [Related]
48. Staphylococcus quorum sensing in biofilm formation and infection.
Kong KF; Vuong C; Otto M
Int J Med Microbiol; 2006 Apr; 296(2-3):133-9. PubMed ID: 16487744
[TBL] [Abstract][Full Text] [Related]
49. Effect of alkaline pH on staphylococcal biofilm formation.
Nostro A; Cellini L; Di Giulio M; D'Arrigo M; Marino A; Blanco AR; Favaloro A; Cutroneo G; Bisignano G
APMIS; 2012 Sep; 120(9):733-42. PubMed ID: 22882263
[TBL] [Abstract][Full Text] [Related]
50. Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections?
Lönn-Stensrud J; Landin MA; Benneche T; Petersen FC; Scheie AA
J Antimicrob Chemother; 2009 Feb; 63(2):309-16. PubMed ID: 19098295
[TBL] [Abstract][Full Text] [Related]
51. Antimicrobial coating agents: can biofilm formation on a breast implant be prevented?
van Heerden J; Turner M; Hoffmann D; Moolman J
J Plast Reconstr Aesthet Surg; 2009 May; 62(5):610-7. PubMed ID: 18359675
[TBL] [Abstract][Full Text] [Related]
52. The control of Staphylococcus epidermidis biofilm formation and in vivo infection rates by covalently bound furanones.
Hume EB; Baveja J; Muir B; Schubert TL; Kumar N; Kjelleberg S; Griesser HJ; Thissen H; Read R; Poole-Warren LA; Schindhelm K; Willcox MD
Biomaterials; 2004 Sep; 25(20):5023-30. PubMed ID: 15109864
[TBL] [Abstract][Full Text] [Related]
53. RIP-V improves murine survival in a sepsis model by down-regulating RNAIII expression and α-hemolysin release of methicillin-resistant Staphylococcus aureus.
Ma B; Zhou Y; Li M; Yu Q; Xue X; Li Z; Da F; Hou Z; Luo X
Pharmazie; 2015 Feb; 70(2):81-7. PubMed ID: 25997246
[TBL] [Abstract][Full Text] [Related]
54. Thiophenones inhibit Staphylococcus epidermidis biofilm formation at nontoxic concentrations.
Lönn-Stensrud J; Naemi AO; Benneche T; Petersen FC; Scheie AA
FEMS Immunol Med Microbiol; 2012 Jul; 65(2):326-34. PubMed ID: 22443118
[TBL] [Abstract][Full Text] [Related]
55. Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin.
Polonio RE; Mermel LA; Paquette GE; Sperry JF
Antimicrob Agents Chemother; 2001 Nov; 45(11):3262-6. PubMed ID: 11600396
[TBL] [Abstract][Full Text] [Related]
56. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms.
Vandecandelaere I; Depuydt P; Nelis HJ; Coenye T
Pathog Dis; 2014 Apr; 70(3):321-31. PubMed ID: 24436195
[TBL] [Abstract][Full Text] [Related]
57. Antibiotic activity against Staphylococcus epidermidis biofilms in dialysis fluids.
Richards GK; Prentis J; Gagnon RF
Adv Perit Dial; 1989; 5():133-7. PubMed ID: 2577396
[TBL] [Abstract][Full Text] [Related]
58. The modulation by fresh and spent peritoneal dialysis fluids of antibiotic kinetics directed against Staphylococcus epidermidis biofilms.
Richards GK; Kostiner GB; Gagnon RF
Adv Perit Dial; 1992; 8():246-9. PubMed ID: 1361798
[TBL] [Abstract][Full Text] [Related]
59. Different sensitivity levels to norspermidine on biofilm formation in clinical and commensal Staphylococcus epidermidis strains.
Ramón-Peréz ML; Díaz-Cedillo F; Contreras-Rodríguez A; Betanzos-Cabrera G; Peralta H; Rodríguez-Martínez S; Cancino-Diaz ME; Jan-Roblero J; Cancino Diaz JC
Microb Pathog; 2015 Feb; 79():8-16. PubMed ID: 25549879
[TBL] [Abstract][Full Text] [Related]
60. Disruption of Staphylococcus epidermidis biofilm formation using a targeted cationic peptide.
Hofmann CM; Bednar KJ; Anderson JM; Marchant RE
J Biomed Mater Res A; 2012 Apr; 100(4):1061-7. PubMed ID: 22318906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
